Association of Lipoprotein(a) and Interleukin-6 With Cardiovascular Risk: MESA and UK Biobank.

Evolving strategies in cardiovascular disease prevention: 2025 American society for preventive cardiology highlights.

2025 ACC/AHA/ASE/ASNC/SCCT/SCMR advanced training statement on advanced cardiovascular imaging: A Report of the ACC Competency Management Committee.

Risk matters for atherosclerotic cardiovascular disease: But vascular resilience may decide.

Opportunistic Detection of Coronary Artery Calcium on Noncardiac Chest Computed Tomography: An Emerging Tool for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association.

Longitudinal Trajectories of Albuminuria and Risk of Subclinical and Clinical Heart Failure, Atrial Fibrillation, and Coronary Heart Disease: the MESA Study.

Global lipoprotein (a) testing trends from 2015 to 2023.

Reply: Sex Differences in the Impact of Exercise Volume on Subclinical Coronary Atherosclerosis: A Meta-Analysis.

Association between cardiovascular-kidney-metabolic syndrome, inflammatory biomarkers, and cardiovascular outcomes: Insights from the MESA study.

2025 ACC/AHA/ASE/ASNC/SCCT/SCMR Advanced Training Statement on Advanced Cardiovascular Imaging: A Report of the ACC Competency Management Committee.